Your browser doesn't support javascript.
loading
Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis.
Nidadavolu, Prakash; Bilkei-Gorzo, Andras; Effah, Felix; Leidmaa, Este; Schürmann, Britta; Berger, Moritz; Bindila, Laura; Schmid, Matthias; Lutz, Beat; Zimmer, Andreas; Bailey, Alexis.
Afiliación
  • Nidadavolu P; Institute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53125 Bonn, Germany.
  • Bilkei-Gorzo A; Institute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53125 Bonn, Germany.
  • Effah F; Pharmacology Section, Institute of Medical and Biomedical Education, St George's University of London, London SW17 0RE, UK.
  • Leidmaa E; Institute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53125 Bonn, Germany.
  • Schürmann B; Institute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53125 Bonn, Germany.
  • Berger M; Department of Medical Biometry, Informatics and Epidemiology, Faculty of Medicine, University of Bonn, 53125 Bonn, Germany.
  • Bindila L; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Schmid M; Department of Medical Biometry, Informatics and Epidemiology, Faculty of Medicine, University of Bonn, 53125 Bonn, Germany.
  • Lutz B; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Zimmer A; Leibniz Institute for Resilience Research (LIR), 55122 Mainz, Germany.
  • Bailey A; Institute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53125 Bonn, Germany.
Int J Mol Sci ; 23(18)2022 Sep 06.
Article en En | MEDLINE | ID: mdl-36142165
ABSTRACT
Endocannabinoid (eCB) signaling is markedly decreased in the hippocampus (Hip) of aged mice, and the genetic deletion of the cannabinoid receptor type 1 (CB1) leads to an early onset of cognitive decline and age-related histological changes in the brain. Thus, it is hypothesized that cognitive aging is modulated by eCB signaling through CB1. In the present study, we detailed the changes in the eCB system during the aging process using different complementary techniques in mouse brains of five different age groups, ranging from adolescence to old age. Our findings indicate that the eCB system is most strongly affected in middle-aged mice (between 9 and 12 months of age) in a brain region-specific manner. We show that 2-arachidonoylglycerol (2-AG) was prominently decreased in the Hip and moderately in caudate putamen (CPu), whereas anandamide (AEA) was decreased in both CPu and medial prefrontal cortex along with cingulate cortex (mPFC+Cg), starting from 6 months until 12 months. Consistent with the changes in 2-AG, the 2-AG synthesizing enzyme diacylglycerol lipase α (DAGLα) was also prominently decreased across the sub-regions of the Hip. Interestingly, we found a transient increase in CB1 immunoreactivity across the sub-regions of the Hip at 9 months, a plausible compensation for reduced 2-AG, which ultimately decreased strongly at 12 months. Furthermore, quantitative autoradiography of CB1 revealed that [3H]CP55940 binding markedly increased in the Hip at 9 months. However, unlike the protein levels, CB1 binding density did not drop strongly at 12 months and at old age. Furthermore, [3H]CP55940 binding was significantly increased in the lateral entorhinal cortex (LEnt), starting from the middle age until the old age. Altogether, our findings clearly indicate a middle-age crisis in the eCB system, which could be a potential time window for therapeutic interventions to abrogate the course of cognitive aging.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Endocannabinoides / Lipoproteína Lipasa Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Endocannabinoides / Lipoproteína Lipasa Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article